Department of Biochemistry and Molecular
Biology, Indiana University School of Medicine and the Walther
Oncology Center, Indianapolis, Indiana
46202-5122,1 and Department of
Genetics, University of Washington, Seattle, Washington
98195-73602
Received 10 August 1998/Returned for modification 21 September
1998/Accepted 5 December 1998
Posttranslational modification of a protein by ubiquitin usually
results in rapid degradation of the ubiquitinated protein by the
proteasome. The transfer of ubiquitin to substrate is a multistep
process. Cdc4p is a component of a ubiquitin ligase that tethers the
ubiquitin-conjugating enzyme Cdc34p to its substrates. Among the
domains of Cdc4p that are crucial for function are the F-box, which
links Cdc4p to Cdc53p through Skp1p, and the WD-40 repeats, which are
required for binding the substrate for Cdc34p. In addition to Cdc4p,
other F-box proteins, including Grr1p and Met30p, may similarly act
together with Cdc53p and Skp1p to function as ubiquitin ligase
complexes. Because the relative abundance of these complexes, known
collectively as SCFs, is important for cell viability, we have sought
evidence of mechanisms that modulate F-box protein regulation. Here we
demonstrate that the abundance of Cdc4p is subject to control by a
peptide segment that we term the R-motif (for "reduced abundance").
Furthermore, we show that binding of Skp1p to the F-box of Cdc4p
inhibits R-motif-dependent degradation of Cdc4p. These results suggest
a general model for control of SCF activities.
 |
INTRODUCTION |
An important mechanism of regulating
protein abundance in eukaryotes is the ubiquitin (Ub)-proteasome
degradation pathway. Ub is a member of a family of conserved
polypeptides that are covalently attached to protein substrates
(reviewed in reference 16). Multiple rounds of
modification create a poly(Ub) chain on the substrate that targets
the substrate for degradation by the proteasome (reviewed in references
4, 12, 14, 15, 42, and 51). The
transfer of free Ub onto a protein substrate is a multistep process. E1
activates free Ub at the expense of ATP. Ub is then transferred to an
E2 (or ubiquitin protein-conjugating enzyme). Based on sequence
comparison, yeast has 11 E2s, and it is believed that each E2 is
responsible for ubiquitinating distinct substrates. Although a free E2
enzyme may directly transfer Ub onto a substrate in a purified system,
this reaction is promoted by additional proteins referred to as E3s or
ubiquitin protein ligases. Some E3s act as intermediary Ub carriers in
the transfer of Ub from E2 to substrate (47). Other E3s act
as adapters, tethering E2 to its substrate (8, 49). It is
emerging that a variety of structurally distinct E3 proteins each serve
to regulate the interaction between E2 proteins and various distinct substrates.
The ubiquitin-proteasome degradation pathway regulates two major cell
cycle events: entry into S phase and entry into anaphase (reviewed
in references 5, 22, and 38). In
yeast, cell cycle progression is mediated by the activity of the
cyclin-dependent kinase (CDK) Cdc28p (reviewed in references
26, 34, and 35). The activation
state and specificity of Cdc28p are determined by cyclins and CDK
inhibitors (reviewed in references 17, 26, 34, 36,
and 43). Association with cyclins Cln1 to Cln3
activates Cdc28p during G1, while the mitotic
cyclins, Clb1 to Clb6, are required for the S through M phases.
Proteins regulating mitosis, including mitotic cyclins, are targeted
for degradation by a cell cycle-regulated E3 complex, the
anaphase-promoting complex. During G1, the CDK
inhibitor Sic1p acts to inhibit CDK-Clb complex formation and
prevent the initiation of S phase. Entry into S phase requires degradation of Sic1p by the ubiquitin-proteasome pathway
(48). We and others have identified components of an E2-E3
complex that is necessary to target Sic1p for degradation (1, 10,
30).
Cells lacking the gene encoding the E2 enzyme Cdc34p remain in
G1, develop multiple elongated buds, and fail to separate
duplicated spindle pole bodies (10). This phenotype is
consistent with failure to activate the Clb-CDK complexes because of
the inability to degrade Sic1p (32, 48). Mutations in two
other genes, CDC4 and CDC53, cause phenotypes
indistinguishable from mutations in CDC34 (30).
Cdc53p is a member of a family of proteins termed cullins (24, 30,
52). Cdc4p is a member of a family of proteins that are
characterized by the presence of WD-40 repeats (37, 53) and
a second motif known as the F-box (1). The entry into S
phase requires CDC34 to act in concert with CDC4
and CDC53 (30). Indeed, we have also shown that
CDC34, CDC4, and CDC53 gene products
form a complex in vivo and that complex formation is necessary for
S phase entry (30, 31). A fourth gene, SKP1 (1, 3), encodes yet another member of this complex, and recombinant Cdc34p, together with Cdc4p, Cdc53p, and Skp1p
produced in insect cells, ubiquitinates Sic1p in vitro (8,
49). Thus, the Cdc4p-Cdc53p-Skp1p complex is an E3 for Cdc34p.
In addition to Cdc4p, two other F-box-containing proteins in yeast,
Met30p (39) and Grr1p (2, 23, 27, 39), have been
proposed to interact with Skp1p and Cdc53p to form complexes referred
as SCFs (for Skp1p-Cdc53p-F box) (8, 39, 40). Like Cdc4p,
both Met30p (50) and Grr1p (9) contain repetitive domains, WD-40 repeats, and leucine-rich repeats, respectively (20), which potentially interact with distinct Cdc34p
substrates. Thus, a family of potential E3 complexes have been
identified that are distinguishable by a component that has been
proposed to recognize distinct substrates.
It has been suggested that each SCF complex contains only one F-box
protein (39, 40). Thus, Cdc4p, Met30p, and Grr1p would compete for a common set of components, namely, Skp1p and Cdc53p. Therefore the relative abundances of F-box-containing proteins must be
tightly regulated. The way in which the cell regulates SCF component
abundance is not clear. Cdc34p is itself a substrate for
ubiquitination, yet cdc34 mutants that are resistant to
Cdc34p ubiquitination have no growth defect (11).
Posttranslational modification of Cdc53p by the Ub-like protein Rub1p
is stimulated when the abundance of Cdc4p and Cdc34p is altered
(25). Furthermore, cells unable to modify Cdc53p by Rub1p
attachment are sensitive to the abundance of Cdc34p and Cdc4p
(25). In the course of performing genetic analysis of
CDC4, we have identified Cdc4p domains that are responsible
for regulating its abundance. We find that the normally low abundance
and short half-life of Cdc4p are dependent on the presence of an
R-motif that is located adjacent to the F-box. Furthermore, we show
that the Skp1p-F-box interaction plays an important role in inhibiting
the destabilizing effect of the R-motif. The results suggest a model
whereby the decision to determine which SCF(s) will be present is
regulated by stabilization of the F-box protein through Skp1p binding.
 |
MATERIALS AND METHODS |
Yeast strains and manipulations.
The yeast strains used in
this study are as follows: A2.7.A3p (MATa cdc4-3
leu2-3,112 his3-11,15), Y382 (MAT
ade2 ade3 ura3 leu2
trp1) (kindly provided by A. Bender), YPH1172 (MATa ura3-52 trp1-
63 his3-
200 leu2-
1 ade2-101
skp1
1::TRP skp1-3::LEU2), YPH1161
(MATa ura3-52 trp1-
63 his3-
200 leu2-
1
ade2-101 skp1
1::TRP skp1-4::LEU2) (both kindly
provided by P. Hieter), MHY803 (MAT
ura3-52 trp1-1 his3-
200
leu2-3,112 lys2-801
doa3::HIS3 [YCplac22
DOA3]), and MHY792 (MAT
ura3-52 trp1-1 his3-
200
leu2-3,112 lys2-801
doa3::HIS3 [YCplac22
doa3-1]) (both kindly provided by M. Hochstrasser).
Standard rich (YPD) and defined minimal SD medium were prepared as
described previously (44). Transformations were carried out
as described previously (7). For plasmid selection, yeast
cells were grown on defined minimal medium supplemented with the
appropriate amino acids. For galactose induction, cells were grown to
early logarithmic phase in minimal medium containing sucrose instead of
dextrose, galactose-containing medium (2%) was added, and the culture
was incubated for a further 2 to 3 h. To measure protein
half-lives, GST-Cdc4p fusions were transiently induced from the
GAL1-10 promoter for 30 min. Glucose (2%) and cycloheximide
(1 mg/ml) were added to repress transcription and translation,
respectively. For complementation experiments, patches derived from
single colonies were grown under permissive conditions (23°C) and
then replica plated and incubated further under nonpermissive conditions (37°C).
Plasmid constructions.
Escherichia coli DH5
was
used to propagate plasmids. Plasmid manipulations were performed by
standard methods (46). Plasmid pSJ4101 has been described
previously (30). The vector pEG(KG) was used for the
expression of glutathione S-transferase (GST) fusion
proteins (33). Expression of the GST fusion proteins was
from the GAL1-10 promoter. All GST-CDC4 fusion constructs were created by cloning PCR-generated DNA fragments with plasmid-borne CDC4 DNA as template by methods as described previously
(29). GST-MET30 fusion constructs were created by cloning
PCR-generated DNA fragments from yeast genomic DNA as the template.
Primers annealing at the 5' end of either CDC4 or
MET30 were designed to incorporate either an XbaI
or a BamHI restriction site, and primers annealing at the 3'
end of either CDC4 or MET30 were designed to
incorporate either a SalI or an AvrII restriction
site. The PCR products were cleaved with the appropriate enzymes and
ligated into pEG(KG), which had previously been digested with the
appropriate enzymes. Table 1 lists
primers used in this study. Table 2 lists the constructs derived from using different sets of primers, which are
numbered to indicate the amino acids from the complete Cdc4p protein
that are encoded. pGST-CDC4(
272-318) was generated by cloning a
PCR fragment generated by CDC48aAvr and NM202b into pGSTCDC4(1-269)(Bam-Xba). This construct replaces residues 272 to 318 with a glycine residue pGST-CDC4(
321-341) was generated by cloning a PCR fragment generated by CDC43aAvr2 and NM202b into pGSTCDC4(1-319). This construct replaces residues 321 to
341 with a glycine residue. pGST-CDC4(L278R) was generated by cloning a PCR fragment generated by CDC4L278R2a and NM202b into
pGSTCDC4(1-L278R). To clone the R-motif, two complementary
oligonucleotides encoding amino acids 320 to 341 were annealed.
BamHI and SalI restriction sites were
incorporated into these oligonucleotides, and following restriction
with these enzymes, the fragment was ligated into pEG(KG) vector
previously cleaved with the same restriction enzymes. A PCR-generated
SKP1 fragment obtained with primers
5'-AAAGGATCCATGGTGACTTCTAATGTTGTC-3' and
5'-GGGGTCGACCTAACGGTCTTCAGCCCATTC-3' was produced.
BamHI and SalI restriction sites were
incorporated into these oligonucleotides, and following restriction
with these enzymes, the fragment was ligated into p424ADH vector
(American Type Culture Collection) cleaved with the same restriction
enzymes. This cloning placed SKP1 under the control of the
ADH1 promoter and allowed for SKP1 overexpression.
Protein preparation and Western immunoblot techniques.
Yeast
lysate preparations and Western immunoblot techniques were carried out
as described previously (29). Antibodies raised against GST
were purchased from Sigma.
 |
RESULTS |
The Cdc4p F-box and WD-40 repeats are required for Cdc4p in vivo
activity.
Cdc4p is a component of a multiprotein complex that is
required for the degradation of two CDK inhibitors, Sic1p
(48) and Far1p (13), as well as Cdc6p (6,
41), which regulates the formation of prereplicative complexes at
origins of DNA replication. The most prominent cdc4 defect
is failure to degrade Sic1p, which prevents the usual cell cycle rise
in Clb-associated CDK activity (48). Cells lacking
cdc4 activity arrest prior to S phase with characteristic multielongated bud morphology. Two domains have been
characterized in Cdc4p that are required for the interaction of Cdc4p
with other members of the complex and for substrate recognition. The
Cdc4p F-box has been proposed to interact with other members of the
complex, which include Skp1p and Cdc53p (39). The Cdc4p WD-40 repeats have been proposed to bind the substrate for
ubiquitination (49). To achieve a further dissection of the
functional domains in Cdc4p, we constructed GST fusion constructs
including various portions of CDC4 (Fig.
1). To assess the function of the
resulting fusion proteins, each construct, as well as the empty vector
and plasmid encoding untagged full-length Cdc4p, was transformed into strain A2.7.A3p, which contains the temperature-sensitive
cdc4-3 allele. Isolated transformants were patched
onto dextrose medium lacking leucine to select for the presence of the
plasmid and then incubated at 23°C, the permissive temperature for
cells containing cdc4-3. These patches were replica plated
to the same media and incubated at 37°C to test the ability of each
GST fusion protein to rescue the temperature-sensitive phenotype of
A2.7.A3p (Fig. 2). Plasmids encoding
full-length untagged Cdc4p [Cdc4(1-779)p] and
GST-Cdc4(269-779)p, which includes both the F-box and the WD-40
repeats, allowed A2.7.A3p cells to grow at the nonpermissive temperature. Neither the plasmid encoding only GST nor plasmids encoding the other GST-Cdc4p fusion proteins permitted growth at the
nonpermissive temperature (Fig. 2), and microscopic examination showed
that these cells displayed the multielongated bud phenotype typical of
loss of CDC4 activity. These findings demonstrate that the
F-box and WD-40 repeat sequences are necessary and sufficient to
complement a cdc4 temperature-sensitive mutant. Furthermore, it is clear that the Cdc4p amino-terminal segment (residues 1 to 278)
is not required for the essential Cdc4p activity in vivo.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 1.
Cdc4p and GST-Cdc4p deletion panel. A schematic diagram
illustrating Cdc4p and the GST-Cdc4p fusion constructs used in this
study is presented. The positions of the F-box, R-motif, and WD-40
repeat motifs are as indicated. Amino acid residues are numbered. Also
indicated is a summary of the biological activities of the different
GST-Cdc4p fusion constructs. The ability of each construct to
complement (+) or failure to complement ( ) cdc4-3 cells is
indicated. The viability (+) or inviability ( ) of Y382 cells when
each construct is overproduced is indicated. The stability of the
indicated construct, as determined by measurement of the half-life of
the protein, is represented as stable (S) or unstable (U/S). ND, not
determined.
|
|

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 2.
Functional Cdc4p domains. A.2.7.A3p cells containing the
cdc4-3 temperature-sensitive mutation were transformed with
a plasmid that allowed the production of the indicated proteins.
Replica patches were made, and cells were incubated at the indicated
temperature for 3 days.
|
|
Identification of dominant lethal and dominant negative Cdc4p
domains.
The plasmids used in the above experiments expressed
CDC4 and GST-CDC4 genes from a
galactose-inducible promoter, GAL1-10. Cells grown in
the presence of dextrose weakly express GAL1-10-controlled genes, whereas cells grown in the presence of galactose strongly express GAL1-10-controlled genes. The fact that Cdc4p
and GST-Cdc4(269-779)p do not have to be overproduced to
rescue the cdc4-3 mutant suggests that only a low level of
full-length Cdc4p is required in the cell. Indeed, we have estimated
that cell viability is maintained when Cdc4p is present at only five
copies per cell (19). Increasing the abundance of one F-box
protein might be expected to have a detrimental effect on the cell,
since it might titrate common SCF components away from other essential
F-box proteins. There is much genetic evidence indicating that the
abundance of SCF components must be balanced to allow normal cell
growth (23, 25, 27, 30, 39). However,
overexpression of genes encoding F-box proteins only has a detrimental
effect on cell growth when the cell also contains mutations in other
SCF components or other F-box proteins. Furthermore, increased
CDC4 transcription does not adversely affect cell growth
(see below) (31). These data suggests that the abundance of
F-box proteins may be regulated in some manner. However, overexpressing
different portions of CDC4 may be detrimental to the cell,
since these Cdc4p fragments may lack potentially self-regulating
sequences. To assess whether the overproduction of the GST-Cdc4 fusion
proteins is toxic to cells containing normal SCF components, Y382 cells
were transformed with each construct described above. Isolated
transformants were grown on sucrose medium lacking leucine to select
for the presence of the plasmid and then transferred to medium
containing galactose as the sole carbon source to induce the expression
of each fusion protein and assess its potential toxicity (Fig.
3A).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 3.
Identification of dominant lethal and dominant negative
Cdc4p domains. (A) Y382 cells, wild type for CDC4, were
transformed with the plasmid that allowed the production of the
indicated protein in the presence of galactose. Transformants were
grown in the presence of sucrose, patched onto medium containing
galactose as the sole carbon source, and incubated for 3 days. (B)
Terminal phenotype of GST-CDC5(1-278) overexpression. (C)
Terminal phenotype of GST-CDC5(341-779) overexpression.
|
|
Overexpression of genes encoding full-length Cdc4p, GST,
GST-Cdc4(1-351)p, and GST-Cdc4(269-779)p did not inhibit the growth of Y382 cells (Fig. 3A). However, overexpression of genes encoding GST-Cdc4(1-269)p and GST-Cdc4(341-779)p did inhibit the growth of
Y382 cells (Fig. 3A). Therefore, overexpressed portions of CDC4 which encode residues 269 to 341 are not toxic to Y382
cells. Cdc4p residues 269 to 341 contain the F-box, a Skp1p binding
polypeptide sequence (1). We next wanted to distinguish
whether the F-box sequence (residues 278 to 319) or the sequence
contiguous with the F-box (residues 320 to 341) was responsible for
alleviating the toxicity when fragments of Cdc4p were overproduced.
Overexpression of genes encoding GST-Cdc4(279-779)p, which
contains a small deletion in the F-box, and GST-Cdc4(319-779)p,
which completely lacks the F-box, did not inhibit Y382 cell growth.
Therefore, residues 320 to 341, and not the F-box, are necessary to
permit cell growth when a potentially toxic fragment of Cdc4p is
overproduced. Finally, we wanted to test whether residues 320 to
341 were necessary to prevent full-length CDC4 from being
toxic when it is overexpressed. A GST-CDC4 gene
overexpressing GST-Cdc4(
320-341)p inhibited cell growth. Therefore,
we have identified a small polypeptide region in Cdc4p,
residues 320 to 341, that is both necessary and sufficient to prevent
cell death when CDC4 is overexpressed.
To begin to understand why overexpression of different regions of CDC4
inhibited cell growth, we carried out microscopic examination of
cells which overproduced GST-Cdc4(1-278)p,
GST-Cdc4(341-779)p, and GST-Cdc4(
320-341)p. Cells overproducing
GST-Cdc4(
320-341)p displayed no cell cycle arrest. Therefore, it is
unlikely that overproduction of this protein interferes with Sic1p
uniquitination and degradation, since cells unable to degrade Sic1p
have a characteristic multielongated bud morphology. The cell death
induced by GST-Cdc4(
320-341)p overproduction may have been due to
loss of essential SCF activities which contain other F-box proteins.
Microscopic examination showed that cells overexpressing
GST-CDC4(1-278) displayed the multielongated bud phenotype
typically seen with loss of CDC4 activity (Fig. 3B). Thus,
overproduction of GST-Cdc4(1-278)p generated a dominant negative
phenotype. Curiously, this amino-terminal domain is
nonessential for Cdc4p activity in vivo (Fig. 2). A possible
explanation for why a nonessential domain generates a dominant lethal
phenotype when overproduced is that some component of the
SCFCdc4p complex partially associates with this region and
is thus titrated away from its essential role in SCFCdc4p
function. However, neither CDC34 nor CDC53
overexpression relieved the toxicity or terminal phenotype induced by
GST-CDC4(1-278) overexpression (data not shown), suggesting
that other SCFCdc4p components that remain unidentified may
interact with Cdc4(1-278)p. Alternatively, residues 1 to 278 may act
as a negative regulator of SCFCdc4p activity.
Overproduction of GST-Cdc4(341-779)p also inhibited the growth of Y382
cells. Microscopic examination showed that these cells also generated
an elongated bud morphology but one that was distinct from the
phenotype seen for loss of CDC4 activity (Fig. 3C). In some
cases buds formed at opposite poles of the elongated cell, whereas
cdc4 cells form multiple buds close to the same site. Cdc4p
residues 341 to 779 contain WD-40 repeats almost exclusively and
have been proposed to interact with SCFCdc4p substrates,
which include Sic1p, Cdc6p, and Far1p. Why overproduction of this Cdc4p
motif is toxic to cells is unclear. Nevertheless, it is clear that
overproducing either fragments of Cdc4p or full-length Cdc4p that lack
residues 320 to 341 is toxic to cells. Thus, residues 320 to 341 may
regulate Cdc4p abundance or activity.
Cdc4p residues 320 to 341 act as a transferable destabilizing
signal.
Since the toxicity of overexpressing CDC4
truncations was ameliorated by the presence of Cdc4p residues 320 to
341, we sought to establish the function of this sequence. Growth
inhibition induced by overproducing different portions of Cdc4p
may be induced by titrating SCF components into a nonfunctioning
complex. Because a number of F-box proteins function in concert
with a common set of SCF components (27, 39, 40),
titrating these components into a nonfunctional complex would result in
loss of activity for a number of SCF complexes. Therefore, one function
of residues 320 to 341 could be to reduce Cdc4p abundance. Thus,
suspecting an effect on protein abundance, we carried out Western blot
analysis with anti-GST antibodies to determine the steady-state
abundance of different GST-Cdc4p fusion proteins (Fig.
4A). We found a clear correlation between
the steady-state abundance of different GST-Cdc4p fusion proteins and
their ability to inhibit cell growth when overproduced (Fig. 4A).
GST-Cdc4(1-278)p and GST-Cdc4(341-779)p, which inhibited cell growth
(Fig. 3A), were both produced to a relatively high abundance with
respect to GST-Cdc4p fusions proteins that were not toxic to cells when
overproduced. Both GST-Cdc4(1-351)p and GST-Cdc4(269-779)p, which do
not inhibit cell growth when overproduced, are low-abundance proteins.
When fused to GST, the region common to these low-abundance proteins,
residues 269 to 351, also reduced the steady-state abundance of GST
(Fig. 4B). We concluded that residues 320 to 341 functioned to reduce
the toxicity of various GST-Cdc4p fusions. When fused to GST, residues 320 to 341 functioned to lower the steady-state abundance of the fusion
protein (Fig. 4B). We named Cdc4p residues 320 to 341 the R-motif,
since this domain is necessary and sufficient to reduce the abundance
of GST-Cdc4p fusions.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 4.
Cdc4p residues 320 to 341 reduce the steady-state
abundance of GST-Cdc4p fusion proteins. Panels A through C show the
anti-GST Western blot of soluble protein extracts from cells expressing
the indicated GST-fusion proteins. A cross-reacting band was used as a
loading control.
|
|
The R-motif, LLISENFVSPKGFNSLNLKLSQ, appears to be a unique sequence,
since we were unable to find significant matches in any database.
However, in Cdc4p it is located adjacent to the F-box, which appears to
be conserved throughout eukaryotes (2, 18, 28, 29, 40, 45).
We next investigated whether an F-box-containing sequence from another
protein might act in a similar fashion. A GST fusion protein was
constructed which contained a 100-amino-acid segment of Met30p that
includes the Met30p F-box (Fig. 4C). Western blot analysis showed that
the addition of this sequence to GST had an effect similar to that of
the corresponding segment of CDC4, severely reducing the
steady-state abundance of GST (Fig. 4C). Fusion of the same Met30p
sequence onto the segment of CDC4 that encodes the WD-40
repeats suppressed the toxicity of the Cdc4p carboxyl terminal when
overproduced in wild-type cells (data not shown). We conclude that
sequences near the F-box from either protein are capable of regulating
the abundance of Cdc4p in a cis-acting manner.
One mechanism by which the R-motif may reduce GST-Cdc4p steady-state
abundance is to target the protein for degradation. To explore this
possibility, we sought to measure the half-lives of different
GST-Cdc4p fusions by promoter shutoff experiments (Fig.
5). GST and GST-Cdc4(341-779)p
were shown to be stable during the time course. However,
GST-Cdc4(269-779)p had a much shorter half-life than
GST-Cdc4(341-779)p. This indicated that residues 269 to 351 were
responsible for the instability of GST-Cdc4(269-779)p. Indeed,
GST-Cdc4(269-351)p, which contains the R-motif, was also shown to
have a short half-life. When fused to GST, the R-motif residues
(residues 320 to 341) were sufficient to decrease the half-life of GST
(Fig. 5). To investigate whether the R-motif is necessary for Cdc4p
degradation, the half-life of a GST-Cdc4p fusion that lacked these
residues was measured. GST-Cdc4(
320-341)p and was stable over
the course of the experiment. Thus, we have shown that GST-Cdc4p
fusions containing the R-motif are rapidly degraded and that the
R-motif is necessary and sufficient for this degradation.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 5.
The R-motif targets Cdc4p for degradation. Time course
experiments to measure the stability of various GST-Cdc4p fusions after
promoter shutoff. The GST-Cdc4p fusions tested are as indicated. The
same cross-reacting band was used as a loading control in each case.
|
|
Finally, we wanted to investigate the mechanism by which Cdc4p may be
degraded. One potential mechanism by which Cdc4p is degraded is by the
ubiquitin-proteasome pathway. To investigate whether Cdc4p is degraded
in a proteasome-dependent fashion GST-CDC4(269-779) was
overexpressed in isogenic cells that either were wild type or contained
a temperature-sensitive allele of an essential proteasome subunit, doa3-1. GST-Cdc4(269-779)p was produced
at the permissive temperature, 23°C, or the restrictive temperature,
36°C, for doa3-1 in both cell types. In cells containing
the wild-type DOA3 allele, the abundance of
GST-Cdc4(269-779)p remained the same at either temperature (Fig.
6). However the abundance of
GST-Cdc4(269-779)p increased in doa3-1 cells incubated
at the restrictive temperature. Thus, Cdc4p abundance appears to
be controlled by a proteasome-dependent pathway.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 6.
Proteasome-dependent degradation of
GST-Cdc4(269-779)p. Cells containing the indicated DOA3
allele were incubated at the indicated temperature. The steady-state
abundance of GST-Cdc4(269-779)p was monitored by Western blot
analysis with anti-GST antibodies.
|
|
The F-box-Skp1p interaction regulates GST-Cdc4p steady-state
abundance.
We have demonstrated that the R-motif is necessary and
sufficient to target GST-Cdc4p for proteasome-dependent degradation. Thus, the R-motif is a negative regulatory sequence for Cdc4p function.
Curiously, the R-motif lies adjacent to the F-box. The F-box is a
polypeptide sequence necessary for Skp1p binding, and the F-box-Skp1p
interaction has been previously noted to stimulate Cdc4p activity
(1). We therefore wanted to investigate whether the function
of the F-box affected R-motif activity. Accordingly, we constructed
specific mutations within the F-box to observe their effects on
GST-Cdc4p abundance (Fig. 7A). We made
two GST-Cdc4p fusions that contained mutations within the F-box: one
lacked the first residue of the F-box, GST-Cdc4(279-779)p, and the
second lacked the F-box, GST-Cdc4(319-779)p. The steady-state
abundance of these GST-Cdc4p fusions was compared with that of similar
constructs that contained wild-type F-box GST-Cdc4(269-779)p.
Western blot analysis (Fig. 7A) showed that the abundance of GST-Cdc4p
fusion was lower in cells containing mutations in the Cdc4p F-box than in cells containing a wild-type Cdc4p F-box. Thus, the effect of the
R-motif is enhanced when mutations are made within the F-box.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 7.
The F-box-Skp1p interaction affects the abundance of
GST-Cdc4p fusions. Panels A through C show the anti-GST Western blot
analysis of soluble protein extracts in cells expressing the indicated
GST-CDC4 genes. (B) Extracts were prepared from cells
containing the indicated SKP1 allele. (C) Extracts were
prepared from cells overexpressing (+) or not overexpressing ( )
SKP1.
|
|
Because the F-box is necessary for Skp1p binding in a variety of
proteins (1, 23, 39), the above results suggest that the
F-box-Skp1p interaction masks the effect of the R-motif. Above, we
have shown that mutating the F-box, which eliminates the ability of
Cdc4p to bind Skp1p, has the effect of reducing the steady-state abundance of GST-Cdc4p. As a second means of testing the significance of the F-box-Skp1p interactions, we measured the GST-Cdc4p fusion abundance when Skp1p activity was limiting. Two temperature-sensitive mutant skp1 alleles that have different terminal
morphologies at the nonpermissive temperature have been described
(3). skp1-3 causes cells to have a
cdc34-like phenotype. The second mutant allele,
skp1-4, generates cells that arrest after S phase and have a
chromosome missegregation phenotype, consistent with a role for
SKP1 in kinetochore function (3, 21). Isogenic
strains containing either skp1-3 or skp1-4 were
transformed with GST-CDC4 fusion constructs encoding either
residues 341 to 779 or 269 to 779, and the relative steady-state
abundance of these proteins was measured by Western blot analysis. We
found that GST-Cdc4(341-779)p, which lacks the F-box, is produced
at very high abundance in the presence of either skp1
allele. However, the abundance of GST-Cdc4(269-779)p, which
contains the F-box, differed between strains containing two different
skp1 alleles. Those containing skp1-4 produced
GST-Cdc4(269-779)p to an abundance equivalent to cells that
contain wild-type SKP1, while skp1-3 cells
produced GST-Cdc4(269-779)p to a much lower abundance (Fig. 7B).
The abundance of GST-Cdc4(269-779)p was further reduced when the
cultures were transferred to the nonpermissive temperature, 37°C, for
skp1 alleles (data not shown). Thus, the integrity of Skp1p
in the cell affects the abundance of an F-box-containing protein.
Furthermore, we noted that many skp1-3 cells became arrested with multiple elongated buds, consistent with the expectation that they
were compromised for SCFCdc4p activity because of low Cdc4p
abundance. Clearly, both Skp1p and the site to which it is known to
bind, the F-box are important in regulating the abundance of Cdc4p.
Finally, we wanted to test whether promoting the Skp1p-F-box
interaction would increase the steady-state abundance. To do this, we
cooverexpressed SKP1 with GST-CDC4 genes that
produced GST-Cdc4p fusions containing a wild-type F-box,
GST-Cdc4(269-779)p, or lacking the F-box, GST-Cdc4(319-779)p.
We observed that the steady-state abundance of GST-Cdc4(269-779)p
was increased when it was co-overexpressed with SKP1 whereas
the steady-state abundance of GST-Cdc4(319-779)p was unaffected
when it was co-overproduced with Skp1p (Fig. 7C). Therefore, the
F-box-Skp1p interaction acts to suppress R-motif mediated degradation.
 |
DISCUSSION |
We have defined domains in Cdc4p that are required for its
function in an active SCF complex. By testing the effects of
overproduction, we have identified domains that cause dominant defects
in cell cycle progression. The presence of a small polypeptide sequence relieves the toxicity of these domains, and we have also shown that
this sequence negatively regulates Cdc4p abundance and targets Cdc4p
for proteasome-dependent degradation. Finally, we have demonstrated that the F-box-Skp1p interaction is necessary to stabilize Cdc4p.
Two domains on Cdc4p are well characterized (Fig. 1). The first is the
F-box, which links Cdc4p to Cdc53p through Skp1p and is required for
the formation of the SCFCdc4p complex. The second consists
of the WD-40 repeats, which are necessary to bind Cdc34p substrates for
ubiquitination. This complex targets Cdc34p substrates for
ubiquitin-dependent degradation. By monitoring complementing activities
of a Cdc4p deletion panel, we have shown that the F-box and WD-40
repeats are both necessary and sufficient to complement a
cdc4 temperature-sensitive mutant (Fig. 2).
By overproducing the panel of Cdc4p deletions, we identified fragments
of Cdc4p that inhibit cell growth (Fig. 3A). We have identified a short
polypeptide region in Cdc4p, which we have termed the R-motif, that is
necessary and sufficient to relieve this toxicity (Fig. 3A). Western
blot analysis demonstrated that the R-motif is necessary and sufficient
to reduce Cdc4p abundance and shorten the half-life of a protein (Fig.
4 and 5). Thus, one function of the R-motif is to reduce the Cdc4p
abundance in the cell. Curiously, the R-motif is essential for Cdc4p in
vivo activity (Fig. 2). Possibly, the R-motif binds additional factors
necessary for SCFCdc4p activity. Alternatively, the R-motif
may confer important structural features to Cdc4p.
There are several possible explanations why overexpressing
cdc4 mutants may cause cell death. It is possible that these
portions of Cdc4p have unregulated ubiquitinating activities and thus
target essential proteins for degradation. However, we favor an
alternative argument. Considerable genetic evidence has indicated
that regulating the abundance of F-box-containing proteins is essential
for cell viability (23, 25, 27, 30, 39) because such
proteins are in competition with one another for binding common
components. Additional evidence that altering the abundance of F-box
proteins affects the activities of other SCFs is seen in the fact that overexpressing GRR1 exacerbates the growth defect of
skp1-11 cells, presumably due to titration of Skp1p away
from Cdc4p and Met30p (27). GRR1 overexpression
also retards the growth of cdc34 and cdc53
mutants (23, 39). However, MET30 overexpression
only weakly affects temperature-sensitive cdc34 and
cdc53 strains and has no effect on skp1 mutants
(39). The reasons for this remain obscure, but Met30p may be
more difficult to overexpress than GRR1. Conversely, loss of
GRR1 suppresses cdc34-1 sic1 cells
(23), which arrest at a later stage in the cell cycle than
cdc34 mutants (48). The reason for this
suppression may be due to the relative abundance of different
F-box-containing proteins. Since cdc34-1 sic1 cells have a
common terminal morphology with cdc4 sic1 cells, it has been
suggested that SCFCdc4p is also required later in the cell
cycle (48). Thus, one means of suppressing cdc34-1
sic1 cells is that the efficiency of SCFCdc4p is
increased. The absence of a nonessential F-box protein would increase
the pool of Skp1p, Cdc53p, and Cdc34p and thereby allow greater
SCFCdc4p efficiency for an uncharacterized G2/M
function (48).
Clearly, regulating the relative abundances of different
F-box-containing proteins is essential for maintaining cell viability. However, the data above has been generated by overproducing one F-box
protein while another SCF component was encoded by a
temperature-sensitive allele. Simply overproducing an F-box protein is
not detrimental to the cell (Fig. 3A). Therefore, it is likely that the
abundance of an F-box protein is self-regulated. Indeed, Cdc4p has
recently been shown to be an unstable protein (54). In this
paper, we have identified a motif on one F-box protein, Cdc4p, that
regulates its abundance. Overexpressing CDC4 that lacks the
R-motif is toxic to cells, although other SCF components are wild type
(Fig. 3A).
It seems unlikely that R-motif activity is unregulated. Unregulated
R-motif activity would probably result in insufficient Cdc4p to
maintain cell viability. During the course of our work, we noted that
mutations in the Cdc4p F-box that presumably disrupt the F-box-Skp1p
interaction reduced the abundance of the GST-Cdc4p fusions (Fig. 7A). A
skp1 allele that specifically hinders SCFCdc4p
function also decreases the abundance of only F-box-containing GST-Cdc4p fusions (Fig. 7B). Finally, overexpressing SKP1
increased the abundance of only GST-Cdc4p that contained an F-box
(Fig. 8C). Taken together, these data demonstrate the importance
of the F-box-Skp1p interaction as a positive regulator of Cdc4p
abundance. This conclusion is supported by other genetic evidence, as
shown by the original isolation of SKP1 as a
high-copy-number suppressor of cdc4 (1).
Increasing the abundance of Skp1p increases the abundance of Cdc4p,
thereby relieving cdc4 temperature sensitivity.
Accordingly, the Skp1p-F-box interaction plays an important role in
regulating Cdc4p abundance and hence SCFCdc4p activity
(Fig. 8). We favor the model that the
binding of Skp1p to the F-box confers stability by preventing the
R-motif from binding other factors that destabilize this protein.
Specifically, failure of the F-box-Skp1p interaction would expose
residues 320 to 341, which would then be capable of binding these
putative destabilizing factors. We note, however, that
sequences similar to residues 320 to 341 do not appear
to be present in other proteins, including other F-box-containing
proteins. Therefore, Cdc4p may interact with specific
destabilization factors which target Cdc4p for removal from the cell
without compromising the abundances of other F-box-containing proteins.
Although Met30p similarly lacks any sequence resembling the Cdc4p
R-motif, we have demonstrated that a sequence near or within the
Met30p F-box also decreases protein abundance (Fig. 4C), and so the
model described in Fig. 8 may hold true for Met30p. Like
Cdc4p, Met30p is also decreased in its abundance in
skp1 mutants (39), suggesting that the
Met30p-F-box-Skp1p interaction similarly modulates Met30p
abundance. Our data for Cdc4p also parallels that for another yeast
protein, Ctf13p, which is involved in kinetochore activity
(21). Ctf13p contains an F-box (40), its
half-life is decreased in skp1 mutants, and it is also
targeted for degradation by the ubiquitin-proteasome pathway
(21). Like Cdc4p, Ctf13p activity requires Skp1p binding (21). Potentially, binding of Skp1p to F-box proteins may
not be necessary for F-box protein biochemical activity but may be needed to prevent F-box protein degradation. The abundance of an
F-box/leucine-rich repeat protein in humans, Skp2, has recently been
shown to oscillate during the cell cycle (28). Whether F-box
and R-motif-like activities are involved in changes in
Skp2 abundance has yet to be explored.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 8.
Skp1p and the Cdc4p F-box act in concert to regulate
Cdc4p abundance. A schematic diagram illustrating the action of two
Cdc4p domains is presented. Skp1p binding to the F-box masks the effect
of the adjacent R-motif. Release of Skp1p exposes the R-motif, which
may recruit proteins that will subsequently target Cdc4p for
degradation.
|
|
Regulating the abundance of F-box proteins is critical for normal
cellular functions. In this paper, we have defined a domain, the
R-motif, that is important in regulating the abundance of Cdc4p.
Overexpression of Cdc4p lacking this region leads to inviability, even
though the cell is wild type for all other SCF components. The precise
mechanism by which the R-motif induces a decrease in Cdc4p steady-state
abundance remains unknown. However, we have provided evidence that
Cdc4p abundance is dependent on the proteasome. Thus, it is likely that
the abundance of an ubiquitin ligase might itself be regulated by
ubiquitin-dependent degradation pathway.
We thank Alan Bender, Phil Hieter, and Mark Hochstrasser for
generously providing strains. We thank Doug Lammer, Peter Roach, and
Ron Wek for stimulating discussions and Doug Lammer and Frank Li for
critical reading of the manuscript.
This work was supported by National Science Foundation grant
MCB-9728069 to M.G.
| 1.
|
Bai, C.,
P. Sen,
K. Hofmann,
L. Ma,
M. Goebl,
J. W. Harper, and S. J. Elledge.
1996.
SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-Box.
Cell
86:263-274[Medline].
|
| 2.
|
Barral, Y.,
S. Jentsch, and C. Mann.
1995.
G1 cyclin turnover and nutrient uptake are controlled by a common pathway in yeast.
Genes Dev.
9:399-409[Abstract/Free Full Text].
|
| 3.
|
Connelly, C., and P. Hieter.
1996.
Budding yeast SKP1 encodes an evolutionarily conserved kinetochore protein required for cell cycle progression.
Cell
86:275-285[Medline].
|
| 4.
|
Coux, O.,
K. Tanaka, and A. L. Goldberg.
1996.
Structure and functions of the 20S and 26S proteasomes.
Annu. Rev. Biochem.
65:801-847[Medline].
|
| 5.
|
Deshaises, R. J.
1995.
The self destructive personality of a cell cycle in transition.
Curr. Opin. Cell Biol.
7:781-789[Medline].
|
| 6.
|
Drury, L. S.,
G. Perkins, and J. F. Diffley.
1997.
The Cdc4/34/53 pathway targets Cdc6p proteolysis in budding yeast.
EMBO J.
16:5966-5979[Medline].
|
| 7.
|
Elbe, R.
1992.
A simple and efficient procedure for transformation of yeasts.
BioTechniques
13:18-20[Medline].
|
| 8.
|
Feldman, R. M.,
C. C. Correll,
K. B. Kaplan, and R. J. Deshaies.
1997.
A complex of Cdc4p, Skp1p, and Cdc53p/Cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sicp.
Cell
91:221-230[Medline].
|
| 9.
|
Flick, J. S., and M. Johnston.
1991.
Grr1 of Saccharomyces cerevisiae is required for glucose repression and encodes a protein with leucine-rich repeats.
Mol. Cell. Biol.
11:5101-5112[Abstract/Free Full Text].
|
| 10.
|
Goebl, M. G.,
J. Yochem,
S. Jentsch,
J. P. McGrath,
A. Varchavsky, and B. Byers.
1988.
The yeast cell cycle gene cdc34 encodes a ubiquitin conjugating enzyme.
Science
241:1331-1334[Abstract/Free Full Text].
|
| 11.
|
Goebl, M. G.,
L. Goetsch, and B. Byers.
1994.
The Ubc3 (Cdc34) ubiquitin-conjugating enzyme is ubiquitinated and phosphorylated in vivo.
Mol. Cell. Biol.
14:3022-3029[Abstract/Free Full Text].
|
| 12.
|
Haas, A. L., and T. J. Siepmann.
1997.
Pathways of ubiquitin conjugation.
FASEB J.
11:1257-1268[Abstract].
|
| 13.
|
Henchoz, S.,
Y. Chi,
B. Catarin,
I. Herskowitz,
R. J. Deshaises, and M. Peter.
1997.
Phosphorylation- and ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor Far1p in budding yeast.
Genes Dev.
11:3046-3060[Abstract/Free Full Text].
|
| 14.
|
Hilt, W., and D. H. Wolf.
1996.
Proteasomes: destruction as a programme.
Trends Biochem. Sci.
21:96-102[Medline].
|
| 15.
|
Hochstrasser, M.
1996.
Ubiquitin-dependent protein degradation.
Annu. Rev. Genet.
30:405-439[Medline].
|
| 16.
|
Hochstrasser, M.
1998.
There's the Rub: a novel ubiquitin-like modification linked to cell cycle regulation.
Genes Dev.
12:901-907[Free Full Text].
|
| 17.
|
Hunter, T.
1993.
Braking the cycle.
Cell
75:839-841[Medline].
|
| 18.
|
Ingram, G. C.,
S. Doyle,
R. Carpenter,
E. A. Schultz,
R. Simon, and E. S. Coen.
1997.
Dual role for fimbriata in regulating floral homeotic genes and cell division in Antirrhinum.
EMBO J.
16:6521-6534[Medline].
|
| 19.
|
Johnson, S. L.
1991.
Structure and functional analysis of the yeast CDC4 gene product. Ph.D. dissertation.
University of Washington, Seattle.
|
| 20.
|
Kajava, A. V.
1998.
Structural diversity of leucine-rich repeat proteins.
J. Mol. Biol.
277:519-527[Medline].
|
| 21.
|
Kaplan, K. B.,
A. A. Hyman, and P. K. Sorger.
1997.
Regulating the yeast kinetochore by ubiquitin-dependent degradation and Skp1p-mediated phosphorylation.
Cell
91:491-500[Medline].
|
| 22.
|
King, R. W.,
R. J. Deshaises,
J.-M. Peters, and M. W. Kirschner.
1996.
How proteolysis drives the cell cycle.
Science
274:1652-1659[Abstract/Free Full Text].
|
| 23.
|
Kishi, T.,
T. Seno, and F. Yamao.
1998.
Grr1 functions in the ubiquitin pathway in Saccharomyces cerevisiae through association with Skp1.
Mol. Gen. Genet.
257:143-148[Medline].
|
| 24.
|
Kipreos, E. T.,
L. E. Lander,
J. P. Wing,
W. W. He, and E. M. Hedgecock.
1996.
cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family.
Cell
85:829-839[Medline].
|
| 25.
|
Lammer, D.,
N. Mathias,
J. M. Laplaza,
W. Jiang,
Y. Liu,
J. Callis,
M. Goebl, and M. Estelle.
1998.
Modification of yeast Cdc53p by the ubiquitin-related protein Rub1p affects function of the SCFCdc4 complex.
Genes Dev.
12:914-926[Abstract/Free Full Text].
|
| 26.
|
Lew, D. L., and S. Reed.
1993.
Morphogenesis in the yeast cell cycle: regulation of Cdc28 by cyclins.
J. Cell Biol.
120:1305-1320[Abstract/Free Full Text].
|
| 27.
|
Li, F., and M. Johnston.
1997.
Grr1 of Saccharomyces cerevisiae is connected to the ubiquitin proteolysis machinery through Skp1: coupling glucose sensing to gene expression and the cell cycle.
EMBO J.
16:5625-5638.
|
| 28.
|
Lisztwan, J.,
A. Marti,
H. Sutterluty,
M. Gstaiger,
C. Wirbelauer, and W. Krek.
1998.
Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2): evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway.
EMBO J.
17:368-383[Medline].
|
| 29.
|
Liu, Y.,
N. Mathias,
C. N. Steussy, and M. G. Goebl.
1995.
Intragenic suppression among CDC34 (UBC3) mutations defines a class of ubiquitin-conjugating catalytic domains.
Mol. Cell. Biol.
15:5635-5644[Abstract].
|
| 30.
|
Mathias, N.,
S. L. Johnson,
M. Winey,
A. E. M. Adams,
L. Goetsch,
J. R. Pringle,
B. Byers, and M. G. Goebl.
1996.
Cdc53 acts in concert with Cdc4 and Cdc34 to control the G1 and S phase transition and identifies a conserved family of proteins.
Mol. Cell. Biol.
16:6634-6643[Abstract].
|
| 31.
|
Mathias, N.,
C. N. Steussy, and M. G. Goebl.
1998.
An essential domain with Cdc34p is required for binding to a complex containing Cdc4p and Cdc53p in Saccharomyces cerevisiae.
J. Biol. Chem.
273:4040-4045[Abstract/Free Full Text].
|
| 32.
|
Mendenhall, M. D.
1993.
An inhibitor of p34CDC28 protein kinase activity from Saccharomyces cerevisiae.
Science
259:216-219[Abstract/Free Full Text].
|
| 33.
|
Mitchell, D. A.,
T. K. Marshall, and R. J. Deschenes.
1993.
Vectors for the inducible overexpression of glutathione S-transferase fusion proteins in yeast.
Yeast
9:715-723[Medline].
|
| 34.
|
Nasmyth, K.
1993.
Control of the yeast cell cycle by the Cdc28 protein kinase.
Curr. Opin. Cell Biol.
5:166-179[Medline].
|
| 35.
|
Nasmyth, K.
1996.
At the heart of the budding yeast cell cycle.
Trends Genet.
12:405-412[Medline].
|
| 36.
|
Nasmyth, K., and T. Hunt.
1993.
Cell cycle. Dams and sluices.
Nature
366:634-635[Medline].
|
| 37.
|
Neer, E. J.,
C. J. Schmidt,
R. Nambudripad, and T. F. Smith.
1994.
The ancient regulatory-protein family of WD-repeat proteins.
Nature
371:297-300[Medline].
|
| 38.
|
Pagano, M.
1997.
Cell cycle regulation by the ubiquitin pathway.
FASEB J.
11:1067-1075[Abstract].
|
| 39.
|
Patton, E. E.,
A. R. Willems,
D. Sa,
L. Kuras,
D. Thomas,
K. L. Craig, and M. Tyers.
1998.
Cdc53 is a scaffold protein for multiple Cdc53/Skp1/F-box protein complexes that regulate cell division and methionine metabolism in yeast.
Genes Dev.
12:692-705[Abstract/Free Full Text].
|
| 40.
|
Patton, E. E.,
A. R. Willems, and M. Tyers.
1998.
Combinatorial control in ubiquitin-dependent proteolysis: don't Skp the F-box hypothesis.
Trends Genet.
14:236-243[Medline].
|
| 41.
|
Piatti, S.,
T. Bohm,
J. H. Cocker,
J. F. Diffley, and K. Nasmyth.
1996.
Activation of S-phase promoting CDKs in late G1 defines a "point of no return" after which Cdc6 synthesis cannot promote DNA replication in yeast.
Genes Dev.
10:1516-1531[Abstract/Free Full Text].
|
| 42.
|
Pickart, C. M.
1997.
Targeting substrates to the 26S proteasome.
FASEB J.
11:1055-1066[Abstract].
|
| 43.
|
Pines, J.
1994.
Arresting developments in cell-cycle control.
Trends Biochem. Sci.
19:143-145[Medline].
|
| 44.
|
Rose, M. D.,
F. Winston, and P. Heiter.
1990.
Methods in yeast genetics: a laboratory course.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 45.
|
Ruegger, M.,
E. Dewey,
W. M. Gray,
L. Hobbie,
J. Turner, and M. Estelle.
1998.
The TIR1 protein of Arabidopsis functions in auxin response and is related to human SKP2 and yeast grr1p.
Genes Dev.
12:198-207[Abstract/Free Full Text].
|
| 46.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 47.
|
Scheffner, M.,
U. Nuber, and J. M. Huibregtse.
1995.
Protein ubiquitination involving an E1-E2-E3 enzyme cascade.
Nature
373:81-83[Medline].
|
| 48.
|
Schwob, E.,
T. Bohm,
M. D. Mendenhall, and K. Nasmyth.
1994.
The B-type cyclin kinase inhibitor p40SIC1 controls the G1 to S transition in S. cerevisiae.
Cell
79:233-244[Medline].
|
| 49.
|
Skowyra, D.,
K. L. Craig,
M. Tyers,
S. J. Elledge, and J. W. Harper.
1997.
F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin ligase complex.
Cell
91:209-219[Medline].
|
| 50.
|
Thomas, D.,
L. Kuras,
R. Barbey,
H. Cherest,
P.-L. Blaiseau, and Y. Surdin-Kerjan.
1995.
Met30p, a yeast transcriptional inhibitor that responds to S-adenosylmethionine, is an essential protein with WD-40 repeats.
Mol. Cell. Biol.
15:6526-6534[Abstract].
|
| 51.
|
Varshavsky, A.
1997.
The ubiquitin system.
Trends Biochem. Sci.
22:383-387[Medline].
|
| 52.
|
Willems, A. R.,
S. Lanker,
E. E. Patton,
K. L. Craig,
T. F. Nason,
N. Mathias,
R. Kobayashi,
C. Wittenberg, and M. Tyers.
1996.
Cdc53 targets phosphorylated G1 cyclins for degradation by the ubiquitin proteolytic pathway.
Cell
86:453-463[Medline].
|
| 53.
|
Yochem, J., and B. Byers.
1987.
Structural comparison of the yeast cell division cycle gene CDC4 and a related pseudogene.
J. Mol. Biol.
195:233-245[Medline].
|
| 54.
|
Zhou, P., and P. Howley.
1998.
Ubiquitination and degradation of the substrate recognition subunits of SCF ubiquitin-protein ligase.
Mol. Cell
2:1-20[Medline].
|